Skip to content

The ACROSS-China trial

Abnormal gluCose Regulation in patients with acute strOke acroSS China: a national multicentre prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN69559777
Enrollment
4000
Registered
2008-05-29
Start date
2008-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal glucose regulation, acute stroke Circulatory System Acute stroke

Interventions

All participants without a history of diabetes mellitus will be identified as having abnormal glucose regulation or not by using the oral glucose tolerance test (OGTT) three days before discharge. The

Sponsors

Bayer (China) Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Older than 18, either sex 2. Acute stroke: diagnosed on World Health Organization (WHO) criteria 3. Acute primary stroke patients within 14 days

Exclusion criteria

Exclusion criteria: 1. Cerebral infarction without symptoms and signs 2. Non-cerebrovascular events 3. Stroke patients out of 14 days 4. Without the content of patients or their legal agents

Design outcomes

Primary

MeasureTime frame
The prevalence of abnormal glucose regulation after acute stroke in China, measured by OGTT before discharge.

Secondary

MeasureTime frame
1. The distribution of stroke subtypes is different in the subtypes of the abnormal glucose regulation 2. The outcome and recurrence risk of stroke in patients with or without abnormal glucose regulation

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026